Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel

Phuong T. Nguyen, Kevin R. DeMarco, Igor Vorobyov, Colleen E. Clancy, Vladimir Yarov-Yarovoy

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


The human voltage-gated sodium channel, hNa V 1.5, is responsible for the rapid upstroke of the cardiac action potential and is target for antiarrhythmic therapy. Despite the clinical relevance of hNa V 1.5-targeting drugs, structure-based molecular mechanisms of promising or problematic drugs have not been investigated at atomic scale to inform drug design. Here, we used Rosetta structural modeling and docking as well as molecular dynamics simulations to study the interactions of antiarrhythmic and local anesthetic drugs with hNa V 1.5. These calculations revealed several key drug binding sites formed within the pore lumen that can simultaneously accommodate up to two drug molecules. Molecular dynamics simulations identified a hydrophilic access pathway through the intracellular gate and a hydrophobic access pathway through a fenestration between DIII and DIV. Our results advance the understanding of molecular mechanisms of antiarrhythmic and local anesthetic drug interactions with hNa V 1.5 and will be useful for rational design of novel therapeutics.

Original languageEnglish (US)
Pages (from-to)2945-2954
Number of pages10
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number8
StatePublished - Feb 19 2019


  • Antiarrhythmic drugs
  • Docking
  • Local anesthetics
  • Molecular dynamics
  • Sodium channel

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel'. Together they form a unique fingerprint.

Cite this